Ticlopidine Oral Tablet 250Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Ticlopidine: Oral tablet (250mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_4786.JPG
Ticlid 250mg Tab
Roche Pharmaceuticals
Pill Identification: Ticlid  |  250
Drug Image file DrugItem_1990.JPG
Ticlopidine 250mg Tab
Apotex Corp
Pill Identification: APO 027 
Drug Image file DrugItem_1828.JPG
Ticlopidine 250mg Tab
Teva Pharmaceuticals USA Inc
Pill Identification: 93  |  154
Drug Image file DrugItem_614.JPG
Ticlopidine 250mg Tab
Actavis Inc. formerly Purepac Pharmaceutical Co
Pill Identification: 613  |  LOGO
Drug Image file DrugItem_5831.JPG
Ticlopidine 250mg Tab
Eon Labs Inc a Division of Sandoz
Pill Identification: E 115 
Drug Image file DrugItem_1387.JPG
Ticlopidine 250mg Tab
Major Pharmaceuticals Inc
Pill Identification: APO 027 
Drug Image file DrugItem_18172.JPG
Ticlopidine 250mg Tab
AvKARE, Inc.
Pill Identification: 154  |  93

What is this Medicine?

TICLOPIDINE (tye KLOE pi deen) helps to prevent blood clots. This medicine is used to prevent strokes in patients who have already had a stroke, or those who are at high risk of having a stroke. This medicine may also be used in combination with aspirin to prevent blood clots in patients who have had a coronary stent placed.

Similar Brand Name Drugs : Ticlid: Oral tablet (250mg)
In-Depth Information
Select a Medication

Ticlopidine Hydrochloride 250mg Tablet

NDC: 001850115
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Transient Ischemic Attack (TIA), Percutaneous Coronary Intervention (PCI), Arterial Thromboembolism Prophylaxis, Stroke Prophylaxis, Thrombosis Prophylaxis

Sometimes used for but not FDA approved for the following conditions:
Acute Myocardial Infarction, Sickle Cell Disease, Myocardial Infarction Prophylaxis, Claudication, Unstable Angina, Diabetic Retinopathy, Peripheral Vascular Disease (PVD)

Ticlopidine Hydrochloride 250mg Tablet
Drug Image file DrugItem_5831.JPG
Eon Labs Inc a Division of Sandoz
Pill Identification: E 115 
Shape: oval
Color: white

Reported Side Effects for Ticlopidine Hydrochloride 250mg Tablet

Cholestasis Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Liver Infection Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Yellow Skin Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Nerve Pain Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Moschcowitz Syndrome Incidence:
<0.1%*
Severity: SEVERE
Onset: DELAYED
Inflamed Blood Vessels Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Anaphylactoid Reactions Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Arthropathy Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Hemolysis Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Liver Failure Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Death Of Liver Tissue Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Lupus-like Symptoms Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Stomach Ulcer Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Kidney Failure Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Aplastic Anemia Incidence:
<0.1%*
Severity: SEVERE
Onset: DELAYED
Erythema Multiforme Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Exfoliative Dermatitis Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Low Blood Sodium Levels Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Nephrotic Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Angioedema Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Stevens-Johnson Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Serum Sickness Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Lung Inflammation Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Weakness Incidence:
0.5-1.0%*
Severity: MILD
Onset: DELAYED
Bleeding In The Brain Incidence:
0.5%*
Severity: SEVERE
Onset: DELAYED
Headache Incidence:
0.5-1.0%*
Severity: MILD
Onset: EARLY
Ringing In Ears Incidence:
0.5-1.0%*
Severity: MILD
Onset: DELAYED
Decreased Appetite Incidence:
1.0%*
Severity: MILD
Onset: DELAYED
Lightheadedness Incidence:
1.1%*
Severity: MILD
Onset: EARLY
Itching Incidence:
1.3%*
Severity: MILD
Onset: RAPID
Gas Incidence:
1.5%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
1.9%*
Severity: MILD
Onset: EARLY
Bruises Incidence:
2.2%*
Severity: MILD
Onset: DELAYED
Low White Blood Cells Incidence:
2.4%*
Severity: MODERATE
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
3.1-7.6%*
Severity: MODERATE
Onset: DELAYED
Stomach Pain Incidence:
3.7%*
Severity: MILD
Onset: EARLY
Skin Rash Incidence:
5.1%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
7.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
7.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
12.5%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Ticlopidine

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5